• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4619872)   Today's Articles (41)   Subscriber (49404)
For: Mihara K, Ogawa A, Matsubara H, Terao T, Ichikawa Y. Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)-An open-label, single-arm study. PLoS One 2018;13:e0195195. [PMID: 29608587 PMCID: PMC5880383 DOI: 10.1371/journal.pone.0195195] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2017] [Accepted: 02/23/2018] [Indexed: 11/18/2022]  Open
Number Cited by Other Article(s)
1
Mohammadi A, Matos WF, Intriago C, Thakkar K, Jahan N, Shah H, Nishu RI, Marzban S. Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension. Cureus 2021;13:e18191. [PMID: 34707962 PMCID: PMC8533662 DOI: 10.7759/cureus.18191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/22/2021] [Indexed: 12/02/2022]  Open
2
The role of miRNA-155 in monocrotaline-induced pulmonary arterial hypertension through c-Fos/NLRP3/caspase-1. Mol Cell Toxicol 2020. [DOI: 10.1007/s13273-020-00083-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA